EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors

Masahiro Okada, Satoru Yamasaki, Go R Sato, Kanako Shimizu, Shin-Ichiro Fujii iD

Molecular Diagnosis & Therapy · 2026-05 · 30 (3) · 495-514

DOI: 10.1007/s40291-026-00842-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Diagnosis & Therapy, online erschienen am 30.03.2026. Verfasst von Masahiro Okada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. Hauptthemen laut MEDLINE: Neoplasms, Antigens, Neoplasm, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntigens, NeoplasmDrug Resistance, NeoplasmHumansCancer VaccinesAnimalsImmunotherapyMolecular Targeted TherapyImmunoinformatics

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
  • Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. shin-ichiro.fujii@riken.jp.
  • RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN, Yokohama, Kanagawa, Japan. shin-ichiro.fujii@riken.jp.

ORCID-Profile: Shin-Ichiro Fujii

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Okada, M., Yamasaki, S., Sato, G. R., Shimizu, K., & Fujii, S. I. (2026). Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors. Molecular Diagnosis & Therapy, 30(3), 495-514. https://doi.org/10.1007/s40291-026-00842-9

Vancouver

Okada M, Yamasaki S, Sato GR, Shimizu K, Fujii SI. Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors. Molecular Diagnosis & Therapy. 2026;30(3):495-514. doi:10.1007/s40291-026-00842-9

BibTeX
@article{Okada2026,
  author = {Okada, Masahiro and Yamasaki, Satoru and Sato, Go R and Shimizu, Kanako and Fujii, Shin-Ichiro},
  title = {Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors},
  journal = {Molecular Diagnosis & Therapy},
  year = {2026},
  volume = {30},
  number = {3},
  pages = {495--514},
  doi = {10.1007/s40291-026-00842-9}
}
Kostenlos starten →